Sentences with phrase «current stock increase»

The current stock increase relative to preindustrial levels is due largely to the past behavior of the rich countries.

Not exact matches

If Mr. Musk were somehow to increase the value of Tesla to $ 650 billion — a figure many experts would contend is laughably impossible and would make Tesla one of the five largest companies in the United States, based on current valuations — his stock award could be worth as much as $ 55 billion (assuming the company does not issue any more shares over the next decade, which is unrealistic).

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

In one month, the stock has grown from $ 3,381 to its current value and, in one year, its portfolio value has increased by more than 40 percent.

Yet the current situation actually creates a double positive for stocks: interest rates are likely to stay lower for longer, which helps support equity valuations while also providing investment - grade issuers with the ability to borrow cheaply and increase shareholder value.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Examples of such projects providing marginal benefits are: improving financial reporting systems through better information technology, minor tweaks to supply chain logistics, cutting back on marketing or increasing low - cost advertising (like social media), «rationalization» of head count, holding average wages as low as possible, squeezing suppliers a little bit, not repatriating earnings to stave off taxation, refinancing rather than retiring debts, and the share buyback that is insensitive to a company's current stock price.

According to data platform Paper.vc, Flipkart's valuation has significantly increased from around $ 13 billion to $ 17 - 19 billion following the move to buy back stock options from over 3,000 current and former employees of the company and its subsidiaries Myntra, Jabong and PhonePe.

This ratio means the market expects the after - tax profits (NOPAT) of XLF stocks to increase 40 % from current levels while KIE stocks are priced for expectations of 10 % NOPAT growth from current levels.

Given the flaws in Netflix's business and the market's increasing awareness of them, holders of NFLX are taking imprudent risk with the stock at anywhere close to its current valuation.

on a pro forma basis, giving effect to (i) the automatic conversion of all of our outstanding shares of convertible preferred stock other than Series FP preferred stock into shares of Class B common stock and the conversion of Series FP preferred stock into shares of Class C common stock in connection with our initial public offering, (ii) stock - based compensation expense of approximately $ 1.1 billion associated with outstanding RSUs subject to a performance condition for which the service - based vesting condition was satisfied as of December 31, 2016 and which we will recognize on the effectiveness of our registration statement in connection with a qualifying initial public offering, as further described in Note 1 to our consolidated financial statements included elsewhere in this prospectus, (iii) the increase in accrued expenses and other current liabilities and an equivalent decrease in additional paid - in capital of $ 187.2 million in connection with the withholding tax obligations, based on $ 16.33 per share, which is the fair value of our common stock as of December 31, 2016, as we intend to issue shares of Class A common stock and Class B common stock on a net basis to satisfy the associated withholding tax obligations, (iv) the net issuance of 7.6 million shares of Class A common stock and 5.5 million shares of Class B common stock that will vest and be issued from the settlement of such RSUs, (v) the issuance of the CEO award, as described below, and (vi) the filing and effectiveness of our amended and restated certificate of incorporation which will be in effect on the completion of this offering.

The pro forma consolidated balance sheet data gives effect to (i) the automatic conversion of all of our outstanding shares of convertible preferred stock other than Series FP preferred stock into shares of Class B common stock and the conversion of Series FP preferred stock into shares of Class C common stock in connection with our initial public offering, (ii) stock - based compensation expense of approximately $ 1.1 billion associated with outstanding RSUs subject to a performance condition for which the service - based vesting condition was satisfied as of December 31, 2016 and which we will recognize on the effectiveness of our registration statement in connection with this offering, as further described in Note 1 to our consolidated financial statements included elsewhere in this prospectus, (iii) the increase in accrued expenses and other current liabilities and an equivalent decrease in additional paid - in capital of $ 187.2 million in connection with the withholding tax obligations, based on $ 16.33 per share, which is the fair value of our common stock as of December 31, 2016, as we intend to issue shares of Class A common stock and Class B common stock on a net basis to satisfy the associated withholding tax obligations, (iv) the net issuance of 7.6 million shares of Class A common stock and 5.5 million shares of Class B common stock that will vest and be issued from the settlement of such RSUs, (v) the issuance of the CEO award, as described below, and (vi) the filing and effectiveness of our amended and restated certificate of incorporation which will be in effect on the completion of this offering.

He treats supply (demand) as increasing or decreasing for a stock when the number of current - month news articles (Google searches) is above or below the 12 - month average, respectively.

Options can help you protect against risk, generate income, increase profits, lower your breakeven point, reverse your strategy without selling your stock, and even potentially let you set a purchase price for a stock below its current market price.

The current stock price implies significant profit growth despite increasing competition, negative margins, and worries over cash flow, which brings us to issue # 6, TSLA's sky high valuation.

Strives to provide dividends that increase over the long term, together with a current yield that exceeds that paid by U.S. stocks in general.

In contrast to other movements in the current account deficit during recent years, which were mainly the result of fluctuations in Australia's trade balance, the most recent increase largely reflected rising payments on Australia's stock of net foreign liabilities — the net income deficit (Graph C1).

At current levels of rates and risk premiums, a mere 1 % increase in the discount rate (from 4.7 % to 5.7 %) would shave nearly 4 P / E points off the stock market's fair value on a trailing earnings basis.

Arsenal target Andrea Belotti has been in sensational form during the current campaign and the Torino striker further increased his stock over the weekend after scoring a stunning eight - minute hat - trick against Palermo.

Testosterone drove these changes in market dynamics by increasing bidding, selling prices, and volume and changed traders» perception of a stock's current value even though true values were known during trading.

«If you want to increase or keep the current number of native animals on your farm it's best to graze with conservative stocking rates and retain standing trees and woody debris.»

With the current low - yielding fixed income environment, I'm sure that a lot of retired investors are looking to dividend stocks as a way to increase their overall portfolio yield.

While Apple's (AAPL) current yield of 2.1 % isn't spectacular, its latest dividend increase of 24 % means that the stock is now offering some of the fastest dividend growth on the market.

If the stock appreciates, the current yield may fall — even as the company increases the dividend.

These early increases, analysts say, are unlikely to derail the current bull market for stocks, because the Fed would be raising rates in response to a growing economy.

If the dividend amount increases by 5 %, but the current yield stays constant, then the price of the stock would have to rise by 5 % a year to make this possible.

Relatively low but not surprising given an 8 year bull market that has increased stock prices, as well as the current low interest rate environment (which means that companies don't need to pay high dividends to attract investors).

With the current state of the U.S. economy and the weakening U.S. dollar, the emphasis on diversification including non-U.S. stocks only seems to be increasing.

«Common stocks of enterprises with only slight possibilities of increasing profits ordinarily sell at a rather low P / E ratio (less than 15 times their current earnings); and the common stocks of companies with good prospects of increasing the earnings usually sell at a high P / E ratio (over 15 times their current earnings).»

The current weakness in global stock markets provides a buying opportunity, which can be used to increase the exposure to stocks at more attractive prices.

There is no guarantee that the issuers of the stocks will declare dividends in the future or that, if dividends are declared, they will remain at their current levels or increase over time.

Given the current low interest - rate environment, adding a high - yield allocation to your core bond portfolio or investing in a multisector bond fund may help increase your investment income — just remember that many of these types of funds still come with the potential for significant volatility, particularly during times of heightened economic and / or stock market volatility.

However, if throughout the year, order levels do increase and support the current forecast or lead to estimate increases for next year, the stock can turn around and increase in value.

For details, see Current Research A and B. Starting from today's valuations and using 2 % TIPS, switching increases the 30 - Year Safe Withdrawal Rate from 3.0 % (with 80 % stocks) or 3.6 % (with 50 % stocks) to 4.2 % (with SwAT) or 4.3 % (with SwOptT).

You can get a sense of whether you ought to increase or decrease the amount you pull from savings by going to a retirement income calculator that uses Monte Carlo assumptions to estimate how long your assets are likely to last and plugging in such information as your nest egg's current balance, how your investments are allocated between stocks and bonds and your planned level of withdrawals.

Over time, the Target Retirement 2030 fund will gradually reduce its stock allocation and increase its bond allocation; in 10 years the allocation should be similar to the current allocation of the Target Retirement 2020 fund.

The most recent increase was 3.1 %, raising the ED stock dividend to its current level of $ 2.68 per share and representing a yield of 3.5 % and a payout ratio of 68 %.

Notice how the dividend (blue line) has continued steadily upward, with annual increases, to its current value of $ 0.66 per share (quarterly), while the stock's price (orange line) has gone up, down, and sideways.

An interesting article on diversifying the current trust fund to include stocks as well as government bonds to increase the rate of return that Paul complains about and lessen the danger pointed out by Foobarista.

When a hedge fund manager increases or decreases a position by a large amount in relation to their current position, it's a more significant move and shows a strong belief, furthermore if a hedge fund have a large portion of their portfolio allocated to a stock it also shows a strong belief that the value will go up.

That «my yield» on our BMY investment is 7.5 % vs. the current dividend yield of 2.5 % reflects 1) steady increases in the company's dividend payout since 2004, and 2) the stock price is much higher today than when we bought it (a stock price rising at a faster rate than the dividend payment will reduce dividend yield).

If the buyback had been completed at the current stock price, the company's per share liquidation value would have increased by around 17 % to $ 6.72.

If the buy back is completed at the current stock price, the company's per share liquidation value will increase by 17 % to $ 6.69, which presents considerable upside from the present price.

If the company undertakes and completes its buy back at the current stock price, HRT's per share liquidating value will increase to $ 4.97, which is 120 % higher than HRT's close yesterday.

If the buy back is completed at the current stock price, the company's per share liquidation value will increase by almost 25 % to $ 7.00.

Furthermore, I fully agree with your words in your current newsletter concerning REITs stock price pressure after interest rate increase.

The game is so ready for you to micromanage, the d - pad «hotkeys» take you to menus to adjust skills and equipment, or check your «stomach stock,» where you keep found items until the next level end (by the way, you can digest these items to increase your current GigaCalories as well), while leaving basic things like healing and restorative items to be hotkeyed to the touch panel.

The petition's outcome may not be fully reflected in current stock prices, but we at ROTH Capital Partners would expect stock volatility to increase as the decision date looms closer.

Increased frequency of droughts along the Atlantic coast (e.g., Ireland) may reduce the productivity of forage crops such that they are no longer sufficient for livestock at current stocking rates without irrigation (Holden and Brereton, 2002, 2003; Holden et al., 2003).

«It is thought that increasing temperatures and / or drought could reduce carbon stocks and also push animals out of current forested areas.